Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
Tonelli, Marcello, Hemmelgarn, Brenda, Reiman, Tony, Manns, Braden, Reaume, M Neil, Lloyd, Anita, Wiebe, Natasha, Klarenbach, Scott
Published in Canadian Medical Association journal (CMAJ) (26.05.2009)
Published in Canadian Medical Association journal (CMAJ) (26.05.2009)
Get full text
Journal Article
Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohort
Juergens, R A, Mariano, C, Jolivet, J, Finn, N, Rothenstein, J, Reaume, M N, Faghih, A, Labbé, C, Owen, S, Shepherd, F A, Villeneuve, J, Romeyer, F, Pettersson, F, Butts, C
Published in Current oncology (Toronto) (01.12.2018)
Published in Current oncology (Toronto) (01.12.2018)
Get full text
Journal Article
Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database
Kushnir, I., Kirk, L., Mallick, R., Kim, R.H., Graham, G.E., Breau, R.H., Lattouf, J.-B., Violette, P.D., Pautler, S.E., Care, M., Kapoor, A., Jewett, M.A.S., Wood, L., Tanguay, S., Heng, D.Y.C., Basappa, N.S., So, A., Pouliot, F., Reaume, N.M.
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.01.2020)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.01.2020)
Get full text
Journal Article
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma
Hotte, S J, Bjarnason, G A, Heng, D Y C, Jewett, M A S, Kapoor, A, Kollmannsberger, C, Maroun, J, Mayhew, L A, North, S, Reaume, M N, Ruether, J D, Soulieres, D, Venner, P M, Winquist, E W, Wood, L, Yong, J H E, Saad, F
Published in Current oncology (Toronto) (01.10.2011)
Published in Current oncology (Toronto) (01.10.2011)
Get full text
Journal Article
Continuity clinics in oncology training programs in Canada
Croke, J M, Vickers, M M, E, C, Heng, D Y, Reaume, M N, Song, X, Meng, J, Asmis, T, Lochrin, C
Published in Current oncology (Toronto) (01.10.2012)
Published in Current oncology (Toronto) (01.10.2012)
Get full text
Journal Article
Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
Fizazi, Karim, Piulats, Josep M., Reaume, M. Neil, Ostler, Peter, McDermott, Ray, Gingerich, Joel R., Pintus, Elias, Sridhar, Srikala S., Bambury, Richard M., Emmenegger, Urban, Lindberg, Henriette, Morris, David, Nolè, Franco, Staffurth, John, Redfern, Charles, Sáez, María I., Abida, Wassim, Daugaard, Gedske, Heidenreich, Axel, Krieger, Laurence, Sautois, Brieuc, Loehr, Andrea, Despain, Darrin, Heyes, Catherine A., Watkins, Simon P., Chowdhury, Simon, Ryan, Charles J., Bryce, Alan H.
Published in The New England journal of medicine (23.02.2023)
Published in The New England journal of medicine (23.02.2023)
Get full text
Journal Article
Web Resource
LBA53Health-related quality of life (HRQL) in a randomized phase III trial of enzalutamide with standard first-line therapy for metastatic, hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led, international, co-operative group trial
Stockler, M R, Martin, A J, Dhillon, H, Davis, I D, Chi, K N, Chowdhury, S, Horvath, L G, Lawrence, N J, Marx, G M, Caffrey, J Mc, McDermott, R, North, S A, Parnis, F, Pook, D W, Reaume, M N, Sandhu, S K, Tan, T H, Thomson, A, Zielinski, R, Sweeney, C J
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Real world outcomes of patients with metastatic renal cell carcinoma (mRCC) using first-line sunitinib or pazopanib: the Canadian experience
Lalani, A.-K., Li, H., Heng, D., Wood, L., Kalirai, A., Bjarnason, G., Sim, H.-W., Kollmannsberger, C.K., Kapoor, A., Hotte, S.J., Vanhuyse, M., Czaykowski, P., Reaume, M.N., Soulieres, D., Venner, P., North, S., Basappa, N.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma
Hotte, S.J., Bjarnason, G.A., Heng, D.Y.C., Jewett, M.A.S., Kapoor, A., Kollmannsberger, C., Maroun, J., Mayhew, L.A., North, S., Reaume, M.N., Ruether, J.D., Soulieres, D., Venner, P.M., Winquist, E.W., Wood, L., Yong, J.H.E., Saad, F.
Published in Current oncology (Toronto) (01.10.2011)
Published in Current oncology (Toronto) (01.10.2011)
Get full text
Journal Article
Determining knowledge transfer gaps in the life cycle of evidence for chemotherapy in non-small cell lung cancer (NSCLC) through cumulative meta-analysis
Reaume, M. N., Nurbhai, M., McGowan, J., O'Rourke, K., Moja, P. L., Evans, W. K., Graham, I. D., Grimshaw, J. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Randomized phase II trial of cisplatin/gemcitabine with or without LY293111, a multiple eicosonaid pathway modulator, in patients with chemotherapy naïve advanced non-small cell lung carcinoma
Janne, P. A., Paz-Ares Rodriguez, L., Gottfried, M., Reaume, M. N., Kaukel, T., Oh, Y. W., Sykes, A., Enas, N., Brail, L. H., Von Pawel, J.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Clinical evidence of efficacy of the temozolomide/gemcitabine combination against non-small cell (nsclc) and small cell (sclc) lung cancers
Goel, R., Gertler, S. Z., Stewart, D. J., Laurie, S. A., Goss, G. D., Reaume, M. N., Cripps, M. C., Bedard, D. A., Rodgers, A., Cutler, D. L.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
A phase I safety and PK study of the novel vascular targeting agent (VTA), Exherin, in patients with refractory solid tumors stratified according to N-cadherin expression
Jonker, D. J., Avruch, L., Stewart, D. J., Goel, R., Goss, G., Dent, S., Reaume, M. N., Spencer, T. A., Peters, W. P.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A phase I safety and PK study of the novel vascular targeting agent (VTA), Exherin, in patients with refractory solid tumors stratified according to N-cadherin expression
Jonker, D. J., Avruch, L., Stewart, D. J., Goel, R., Goss, G., Dent, S., Reaume, M. N., Spencer, T. A., Peters, W. P.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article